Quotes 5-day view Delayed Nyse
01/11/2021
01/12/2021
01/13/2021
01/14/2021
01/15/2021
Date
159(c)
159.83(c)
162.95(c)
162.62(c)
160.12(c)
Last
1 201 729
1 176 974
1 675 412
1 145 693
1 405 802
Volume
+0.03% +0.52% +1.95% -0.20% -1.54% Change
Sales 2020
7 040 M - -
Net income 2020
-175 M - -
Net Debt 2020
6 852 M - -
P/E ratio 2020
-183x
Yield 2020
0,61%
Sales 2021
8 099 M - -
Net income 2021
1 122 M - -
Net Debt 2021
5 399 M - -
P/E ratio 2021
30,4x
Yield 2021
0,63%
Capitalization
33 189 M 33 189 M -
EV / Sales 2020
5,69x
EV / Sales 2021
4,76x
Nbr of Employees
19 900
Free-Float
66,5%
Zimmer Biomet Holdings specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows:
- reconstruction implants (59.4%): knees replacement (59.2% of net sales), hips replacement (40.8%) ;
- surgical products and traumatology equipment (22.5%);
- spinal implants (9.4%);
- dental...
Notations Surperformance© of Zimmer Biomet Holdings
Trading Rating : Investor Rating :
All news about ZIMMER BIOMET HOLDINGS
News in other languages on ZIMMER BIOMET HOLDINGS
Analyst Recommendations on ZIMMER BIOMET HOLDINGS
Chart ZIMMER BIOMET HOLDINGS
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short Term Mid-Term Long Term Trends Bullish Bullish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
30
Average target price
167,21 $
Last Close Price
160,12 $
Spread / Highest target
20,5%
Spread / Average Target
4,43%
Spread / Lowest Target
-33,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
